4.1 Article

Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners

Journal

MEDCHEMCOMM
Volume 8, Issue 8, Pages 1659-1667

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c7md00247e

Keywords

-

Funding

  1. Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases
  2. Inserm, Univ. Lille, France
  3. UGC, India
  4. National Heart, Lung, and Blood Institute [R01HL133589]

Ask authors/readers for more resources

A pyrazolo[4,3-e][1,2,4] triazolo[1,5-c] pyrimidin-5-amine antagonist of the A(2A) adenosine receptor (AR) was functionalized as amine congeners, fluorescent conjugates and a sulfonate, and the A(2A)AR binding modes were predicted computationally. The optimal n-butyl spacer was incorporated into the following A(2A)AR-selective (K-i, nM) conjugates: BODIPY630/650 derivative 11 (MRS7396, 24.6) and AlexaFluor488 derivative 12 (MRS7416, 30.3). Flow cytometry of 12 in hA(2A)AR-expressing HEK-293 cells displayed saturable binding (low nonspecific) and inhibition by known A(2A)AR antagonists. Water-soluble sulfonate 13 was a highly potent (K-i = 6.2 nM) and selective A(2A)AR antagonist based on binding and functional assays. Docking and molecular dynamics simulations predicted the regions of interaction of the distal portions of these chain-extended ligands with the A(2A)AR. The BODIPY630/650 fluorophore of 11 was buried in a hydrophobic interhelical (TM1/TM7) region, while AlexaFluor488 of 12 associated with the hydrophilic extracellular loops. In conclusion, we have identified novel high affinity antagonist probes for A(2A)AR drug discovery and characterization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available